Brief: OncBioMune broadens portfolio, partners and product with Vitel acquisition
11/11/2016 14:10
Nov 11 (Reuters) - Oncbiomune Pharmaceuticals Inc OBMP.PK :
* Oncbiomune broadens portfolio, partners and product with
Vitel acquisition
Source text for Eikon: ID:nMKWvwpN2a
Further company coverage: OBMP.PK
((bangalore.newsroom@thomsonreuters.com;))
Recent news on Theralink Technologies
See all newsBrief: IMAC Holdings - Theralink Will Merge With Newly-Formed Unit Of IMAC In A Stock-For-Stock Reverse Merger Transaction
Patient selection for AstraZeneca, Daiichi breast cancer drug needs improvement, experts say (updated)
Patient selection for AstraZeneca, Daiichi breast cancer drug needs improvement, experts say
Brief: Theralink Technologies Appoints Faith Zaslavsky As President, COO
Brief: Theralink Technologies Appoints Mattia Cremona As Director Of Its Biopharma Laboratory